Kavitt Robert T, Hirano Ikuo, Vaezi Michael F
Section of Gastroenterology, Hepatology, and Nutrition, University of Chicago, Ill.
Division of Gastroenterology, Feinberg School of Medicine, Northwestern University, Chicago, Ill.
Am J Med. 2016 Sep;129(9):924-34. doi: 10.1016/j.amjmed.2016.04.024. Epub 2016 May 4.
Eosinophilic esophagitis is a relatively recently discovered disease of increasing incidence and prevalence and is a common cause of dysphagia and food bolus impaction. The definition of eosinophilic esophagitis continues to evolve, most recently with the characterization of proton pump inhibitor-responsive esophageal eosinophilia. The number of high-quality prospective, controlled trials guiding therapeutic decisions in eosinophilic esophagitis has increased steadily over the past several years. Treatment options at present focus on dietary therapy, particularly implementation of a 6-food elimination diet, and medical therapy, primarily the use of swallowed, topical corticosteroids. Proton pump inhibitors play an important role in current management. Conservative esophageal dilation is effective at ameliorating dysphagia in symptomatic patients with esophageal strictures. We conducted an evidence-based review of the diagnosis and treatment options in adults with eosinophilic esophagitis. The understanding of eosinophilic esophagitis continues to be refined. Continued validation of appropriate endpoints, however, is essential to establish the efficacy of existing and novel therapeutic approaches.
嗜酸性粒细胞性食管炎是一种相对较新发现的疾病,其发病率和患病率呈上升趋势,是吞咽困难和食物团块嵌塞的常见原因。嗜酸性粒细胞性食管炎的定义仍在不断演变,最近质子泵抑制剂反应性食管嗜酸性粒细胞增多症的特征得以明确。在过去几年中,指导嗜酸性粒细胞性食管炎治疗决策的高质量前瞻性对照试验数量稳步增加。目前的治疗选择集中在饮食疗法,特别是实施六食物排除饮食,以及药物治疗,主要是使用吞咽的局部皮质类固醇。质子泵抑制剂在当前治疗中发挥着重要作用。保守的食管扩张术对于改善有食管狭窄症状患者的吞咽困难有效。我们对成人嗜酸性粒细胞性食管炎的诊断和治疗选择进行了循证综述。对嗜酸性粒细胞性食管炎的认识仍在不断完善。然而,持续验证适当的终点对于确定现有和新治疗方法的疗效至关重要。